Brompton Funds Provides Update on Global Healthcare Income & Growth Fund

TORONTO, ONTARIO -- (Marketwired) -- 04/15/16 -- Investors and investment advisors are invited to listen to an update on Global Healthcare Income & Growth Fund (the "Fund") (TSX: HIG.UN), hosted by Senior Portfolio Manager Laura Lau and Portfolio Manager Michael Clare of Brompton Funds. The Portfolio Managers discuss the Fund's portfolio and the Healthcare sector. The Manager believes that current valuations for Healthcare companies are attractive given their strong growth prospects, defensive characteristics and exposure to secular trends that will drive healthcare spending for decades to come. A link to the replay of the update recorded on April 14, 2016 has been posted to the Brompton Funds website at www.bromptongroup.com.

The Fund has been created to provide investors with exposure to an equal-weight portfolio of equity securities of large capitalization global healthcare companies, providing the opportunity for capital appreciation, and the opportunity for enhanced distributions and higher risk-adjusted returns due to an active covered-call writing program. The Fund has a current distribution of $0.60 per unit per annum, representing a cash distribution rate of 7.3% based on the April 12, 2016 TSX closing price.

The Fund's portfolio is comprised of the shares of the following companies:

AbbVie Inc                Cardinal Health Inc      Pfizer Inc
Allergan PLC              Celgene Corp             Roche Holding AG
Bayer AG                  CVS Health Corp          Stryker Corp
Becton Dickinson and Co   Gilead Sciences Inc      Thermo Fisher Scientific
Biogen Inc                Johnson & Johnson        Inc
Bristol-Myers Squibb Co   Laboratory Corp of       UnitedHealth Group Inc
Boston Scientific Corp    America Holdings         United Therapeutics Corp
Baxalta Inc               Medtronic PLC            Zimmer Biomet Holdings
                                                   Inc

About Brompton Funds

Brompton Funds, a division of Brompton Group which was founded in 2000, is an experienced investment fund manager with approximately $2.0 billion in assets under management. Brompton's investment solutions include TSX listed closed-end funds, mutual funds, hedge funds and flow-through limited partnerships. For further information, please contact your investment advisor, call Brompton's investor relations line at 416-642-6000 (toll-free at 1-866-642-6001), email [email protected] or visit our website at www.bromptongroup.com.

You will usually pay brokerage fees to your dealer if you purchase or sell units of the investment fund on the Toronto Stock Exchange or other alternative Canadian trading system (an "exchange"). If the units are purchased or sold on an exchange, investors may pay more than the current net asset value when buying units of the investment fund and may receive less than the current net asset values when selling them.

There are ongoing fees and expenses associated with owning units of an investment fund. An investment fund must prepare disclosure documents that contain key information about the Fund. You can find more detailed information about the Fund in the public filings available at www.sedar.com. Investment funds are not guaranteed, their values change frequently and past performance may not be repeated.

Certain statements contained in this news release constitute forward-looking information within the meaning of Canadian securities laws. Forward-looking information may relate to matters disclosed in this news release and to other matters identified in public filings relating to the Fund, to the future outlook of the Fund and anticipated events or results and may include statements regarding the future financial performance of the Fund. In some cases, forward-looking information can be identified by terms such as "may", "will", "should", "expect", "plan", "anticipate", "believe", "intend", "estimate", "predict", "potential", "continue" or other similar expressions concerning matters that are not historical facts. Actual results may vary from such forward-looking information. Investors should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and we assume no obligation to update or revise them to reflect new events or circumstances.

Contacts:
Brompton's Investor Relations line
416-642-6000 (toll-free at 1-866-642-6001)
[email protected]
www.bromptongroup.com

Source: Global Healthcare Income & Growth Fund

You May Also Be Interested In

• Dimensional Fund Advisors Ltd. : Form 8.3 - ROTORK PLC - Ordinary Shares
• Integrated Quantum Technologies Launches New Corporate Website, Investor Presentation and Announces Stock Option Grant
• UMHS Celebrates Residency Match Success with 94% Overall Match Rate and Inspiring Student Journeys